Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Alembic Pharma to raise Rs 1000 crore via QIP issue of equity shares

Ruchika Sharma28 July 2020 4:52 PM IST

New Delhi: Gujarat-based drug firm, Alembic Pharmaceuticals, on Monday said its board has shown a green signal to raise up to Rs 1,000 crore...

Granules India clarifies on recall of 4.78 lakh bottles of Metformin Hydrochloride ER tablets in US

Ruchika Sharma28 July 2020 3:14 PM IST

Hyderabad: Over the past weekend, there were several media sources that claimed that Granules India recalls 4.78 lakh bottles of diabetes drugs-...

Serum Institute of India conducts phase III trial of BCG vaccine for COVID-19

Ruchika Sharma28 July 2020 1:32 PM IST

The DBT statement quoting Adar Poonawalla, the owner and CEO of Serum Institute of India(SII) said,"We are delighted to partner with DBT-BIRAC for...

Dr Reddy's Labs gets USFDA nod for lice treatment lotion XEGLYZE in US

Ruchika Sharma28 July 2020 12:42 PM IST

XEGLYZE is indicated for the topical treatment of head lice infestation in patients 6 months of age and older.

Avra Labs secures CDSCO nod to manufacture, market Favipiravir API

Ruchika Sharma28 July 2020 12:11 PM IST

Hyderabad: Avra Laboratories Pvt Ltd, a city based pharma company, has been granted regulatory approval by the Central Drugs Standard Control...

Setback to Biocon: Health Ministry Says NO To Psoriasis Drug Itolizumab In Clinical Management Protocols For COVID-19

Ruchika Sharma27 July 2020 3:59 PM IST

New Delhi: In a major setback to drug major, Biocon, the National Task Force on COVID-19 has decided against including Itolizumab drug in clinical...

COVID-19 Vaccine: Serum Institute of India seeks DCGI nod for Phase 2/3 trials

Ruchika Sharma27 July 2020 1:13 PM IST

The domestic pharma giant has partnered with AstraZeneca for manufacturing the Oxford vaccine candidate for the highly infectious disease -- COVID-19.

COVID-19: First part of phase-1 of Covaxin human trial concluded with encouraging results

Ruchika Sharma27 July 2020 12:20 PM IST

Rohtak: The first part of phase-1 of Covaxin human trial completed on Saturday at Post-Graduate Institute (PGI) of Medical Sciences, Rohtak, said Dr...

Lupin, Granules India recall diabetes drug Metformin Hydrochloride ER tablets in US

Ruchika Sharma27 July 2020 11:40 AM IST

As per the USFDA, the companies are recalling the product due to deviation from the current good manufacturing practices (CGMP).

Independent scientists, ethicists charged for developing guidelines for distribution of eventual COVID-19 vaccine

Ruchika Sharma27 July 2020 9:15 AM IST

Chicago: U.S. public health officials on Friday charged a group of independent scientists and ethicists with developing guidelines to determine who...

Sanofi begins shipment of influenza vaccine doses in US

Ruchika Sharma26 July 2020 9:00 AM IST

Bridgewater: Sanofi Pasteur, the vaccines global business unit of Sanofi, has shipped the first of its influenza vaccine doses to health care...

Alembic Pharma Secures USFDA Tentative Approval for Bosulif Generic Bosutinib 400 mg

Alembic Pharma Q1 Profit jumps to Rs 301.46 crore

Ruchika Sharma25 July 2020 9:30 AM IST

New Delhi: Drug firm Alembic Pharmaceuticals on Wednesday reported more than two-fold jump in consolidated net profit to Rs 301.46 crore for the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok